Application Information

This drug has been submitted to the FDA under the reference 205879/001.

Names and composition

"INVOKAMET XR" is the commercial name of a drug composed of CANAGLIFLOZIN and METFORMIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205879/001 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 500MG
205879/002 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 1GM
205879/003 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 150MG and 500MG
205879/004 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 150MG and 1GM

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204353/001 INVOKAMET CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 500MG
204353/002 INVOKAMET CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 50MG and 1GM
204353/003 INVOKAMET CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 150MG and 500MG
204353/004 INVOKAMET CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET/ORAL 150MG and 1GM
205879/001 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 500MG
205879/002 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 50MG and 1GM
205879/003 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 150MG and 500MG
205879/004 INVOKAMET XR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE/ORAL 150MG and 1GM

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved